Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Free Cash Flow: 2009-2024

Historic Free Cash Flow for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • UNITED THERAPEUTICS's Free Cash Flow rose 16.93% to $351.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 24.92%. This contributed to the annual value of $1.1 billion for FY2024, which is 44.54% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Free Cash Flow of $1.1 billion as of FY2024, which was up 44.54% from $747.6 million recorded in FY2023.
  • UNITED THERAPEUTICS's 5-year Free Cash Flow high stood at $1.1 billion for FY2024, and its period low was $477.4 million during FY2021.
  • Moreover, its 3-year median value for Free Cash Flow was $747.6 million (2023), whereas its average is $830.6 million.
  • In the last 5 years, UNITED THERAPEUTICS's Free Cash Flow skyrocketed by 339.89% in 2020 and then slumped by 31.45% in 2021.
  • Over the past 5 years, UNITED THERAPEUTICS's Free Cash Flow (Yearly) stood at $696.4 million in 2020, then slumped by 31.45% to $477.4 million in 2021, then soared by 39.02% to $663.7 million in 2022, then climbed by 12.64% to $747.6 million in 2023, then surged by 44.54% to $1.1 billion in 2024.